Brief: Instil Bio reports Q2 results
12/08/2022 12:03
Aug 12 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* INSTIL BIO INC - CASH RUNWAY EXPECTED TO EXTEND FROM 2024
INTO
2025 UPON COMPLETION OF ANTICIPATED SALE-LEASEBACK OF TARZANA,
CA MANUFACTURING SITE
* INSTIL BIO INC QTRLY NET LOSS PER SHARE, BASIC AND DILUTED
$0.46
Source text for Eikon: ID:nGNX2WMW1K
Further company coverage: TIL.O
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses